UV-Visible spectrophotometry of Repaglinide in bulk and in formulation by using methyl orange as reagents

Journal of the Iranian Chemical Research

مقاله 1، دوره 4، شماره 2، شهریور 2011، صفحه 69-76   

نویسندگان

Smita Sharma^{* 1}؛ Mukesh Chandra Sharma²

¹Department of Chemistry Chodhary Dilip Singh Kanya Mahavidyalya Bhind (M.P) 477001, India

²School of Pharmacy, Devi Ahilya Vishwavidyalaya, Indore (M.P)-452001, India

چکیده

Two sensitive spectrophotometric methods are presented for the assay of Repaglinide in bulk
drug and in formulations using methyl orange, as reagents. Oxidant by reacting with a fixed
amount of either methyl orange and measuring the absorbance at 485.2 nm (method-I) and
measuring the absorbance at 618.9 nm (method-II). Developed method is based on the formation
of extractable colored complex of drug with coloring agent Methyl orange dye. A wavelength
maximum was found to be 618.9 nm. The concentration range of 15-50 μg ml-1 with linear
regression of 0.9995, while the percentage recovery, LOD and LOQ were 99.42-99.08 %, 2.17
μg ml-1 and 1.08 μg ml-1 respectively. The result of analysis have been validated statistically and
also by recovery studies. From the percentage recovery and specificity studies it was concluded
that there was no interference of common additives during the estimation. This proves the
suitability of this method for the routine quality control analysis of the Repaglinide in
formulation.

کلیدواژه‌ها

Repaglinide؛ Derivative spectrophotometry؛ Area under curve

مراجع

[1] M.D.Rockville, United States Pharmacopoeia; 25th (Eds) United States Pharmacopoeial Convention
Inc, (2002) 2150.
[2] S.Budavari, the Merck Index. 13th (eds) Whitehouse Station (NJ, USA) Merck and Co Inc (2001) 790.
[3] J.E.F Reynolds, Martindale, 33 rd ed. (London), the Complete Drug Reference Pharmaceutical Press,
(2002) 334.
[4] M.D. Rockville, United State Pharmacopoeia, (Asian Eds) USP Convention Inc, (2003) 623.
[5] A.B. Ruzilawati, M.S. Wahab, A. Imran, Z. Ismail, S.H. Gan, J. Pharm. Biomed. Anal. 43 (2007)
1831-1835.
[6] M. Gandhimathi, T.K. Ravi, S.K. Renu, Anal. Sci. 19 (2002) 1675-1677.
[7] R.H. Khan, S. Talegaonkar, R.M. Singh, S.C. Mathur, R. Shiv, G.N. Singh, Indian Drugs 44 (2007)
428-433.
[8] A. Gumieniczek, A. Berecka, H. Hopkała, J. Planar Chromatogr. 18 (2005) 155-159.
Parameters Repaglinide
Method I Method II
Working λ (nm) 485.2 nm
618.9 nm
Beer’s law limit (μg mL-1) 5-35 5-35 5-35 0-45
Correlation coefficient * 0.9965 0.9994 0.9998 0.9999
Intercept * 0.0003 0.0014 0.0043 0.0021
Slope * 0.0143 0.0221 0.0651 0.0765
Limit of detection, μg mL-1 2.17 -0.74
Limit of quantification, μg mL-1 1.08 0.18
S. Sharma & M.Ch. Sharma / J. Iran. Chem. Res. 4 (2011) 69-76
76
[9] A. Goyal, I. Singhvi, Indian. J. Pharm. Sci. 68 (2006) 656-657.
[10] ICH, Stability Testing of New Drug Substances and Products, in: Proceeding of the International
Conference on Harmonisation, IFPMA, Geneva, (2003).
[11] M. Bakshi, S. Singh, J. Pharm. Biomed. Anal. 28 (2003) 1011-1040.
[12] A.B. Thomas, M.R. Patankar, K.R. Deshmukh, L.P. Kothapalli, S.J. Jangam, S.H. Bodkhe, A.D.
Deshpande, Indian Drugs 44 (2007) 745-750.
[13] S.B. Chepurwar, A.A. Shirkhedkar, S.B. Bari, S.J. Surana, S.J. Indian Drugs 43 (2006) 803-806
[14] A.G. Davison, A.H. Beckette, J.B. Stenlake, Practical Pharmaceutical Chemistry, CBS Publishers
and distributors, New Delhi.275 (1997).